Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
Abstract DNA vaccination against cancer has become a promising strategy for inducing a specific and long-lasting antitumor immunity. However, DNA vaccines fail to generate potent immune responses when used as a single therapy. To enhance their activity into the tumor, a DNA vaccine against murine P8...
Saved in:
Main Authors: | Alessandra Lopes, Kevin Vanvarenberg, Špela Kos, Sophie Lucas, Didier Colau, Benoît Van den Eynde, Véronique Préat, Gaëlle Vandermeulen |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/8a185f7e782e4e90bd9cd7722f8cbb6c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Solitary Bullous Mastocytoma with Dermoscopic Features in a Neonate
by: Özge Gündüz, et al.
Published: (2019) -
Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas
by: Hongkai Zhuang, et al.
Published: (2021) -
CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015) -
Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications
by: Hannah-Lou Schilling, et al.
Published: (2021) -
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab
by: Rosaria De Filippi, et al.
Published: (2021)